CPHI India reports surge in exhibitor numbers
Modernization and supply chain diversity drive new growth
Modernization and supply chain diversity drive new growth
Gross Profit stood at Rs. 36.02 crore compared to Rs. 20.42 crore during Q2FY24, a significant increase of 76.40%
In Q2 FY25, our crop protection segment reported revenue of Rs. 159 crore, with an EBIT margin of 5%
Combined capabilities to drive novel healthcare applications presented at MEDICA 2024
JB’s domestic business continued to out-perform the market with all our major brands posting strong growth
The new range incorporates a product that also contains the S-PRG filler employed in the Giomer range
Revenue at Rs 3,623 crore, EBITDA at Rs 718 crore
The inspection concluded with the issuance of Form 483 with four observations which are procedural in nature
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
JB’s absolute Scope1 & Scope2 emissions reduced by 13.9 % in the last financial year, despite turnover increasing by 11%
Subscribe To Our Newsletter & Stay Updated